The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors
Viruses · 2023
DOI: 10.3390/v15112234 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Lívia da Rocha Fernandes und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil. Hauptthemen laut MEDLINE: Anti-HIV Agents, Prodrugs, Acquired Immunodeficiency Syndrome, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Pró-reitoria de Pesquisa - UNESP - Edital 01/2023-PROPe/PROPEG..
Abstract (Originalsprache)
Antiretroviral Therapy (ART) is an effective treatment for human immunodeficiency virus (HIV) which has transformed the highly lethal disease, acquired immunodeficiency syndrome (AIDS), into a chronic and manageable condition. However, better methods need to be developed for enhancing patient access and adherence to therapy and for improving treatment in the long term to reduce adverse effects. From the perspective of drug discovery, one promising strategy is the development of anti-HIV prodrugs. This approach aims to enhance the efficacy and safety of treatment, promoting the development of more appropriate and convenient systems for patients. In this review, we discussed the use of the prodrug approach for HIV antiviral agents and emphasized nucleoside reverse transcriptase inhibitors. We comprehensively described various strategies that are used to enhance factors such as water solubility, bioavailability, pharmacokinetic parameters, permeability across biological membranes, chemical stability, drug delivery to specific sites/organs, and tolerability. These strategies might help researchers conduct better studies in this field. We also reported successful examples from the primary therapeutic classes while discussing the advantages and limitations. In this review, we highlighted the key trends in the application of the prodrug approach for treating HIV/AIDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, Brazil.
ORCID-Profile: Juliana Romano Lopes, Andressa Francielli Bonjorno, Cauê Benito Scarim, Jean Leandro Dos Santos
Förderung
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Pró-reitoria de Pesquisa - UNESP - Edital 01/2023-PROPe/PROPEG.
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Pró-reitoria de Pesquisa—UNESP
Zitieren
APA
Fernandes, L. D. R., Lopes, J. R., Bonjorno, A. F., Prates, J. L. B., Scarim, C. B., & Dos Santos, J. L. (2023). The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors. Viruses. https://doi.org/10.3390/v15112234
Vancouver
Fernandes LDR, Lopes JR, Bonjorno AF, Prates JLB, Scarim CB, Dos Santos JL. The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors. Viruses. 2023. doi:10.3390/v15112234
BibTeX
@article{Fernandes2023,
author = {Fernandes, Lívia da Rocha and Lopes, Juliana Romano and Bonjorno, Andressa Francielli and Prates, João Lucas Bruno and Scarim, Cauê Benito and Dos Santos, Jean Leandro},
title = {The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15112234}
}
EUVIMED